AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 33914190 — intervention group
Group type: EXPERIMENTAL
Intervention: Step time variability
Number of subjects: 351
Study 32925039 — intervention group
Group type: EXPERIMENTAL
Intervention: Dietary Approaches to Stop Hypertension (DASH)
Number of subjects: 132
Study 32925039 — intervention group
Group type: EXPERIMENTAL
Intervention: Both AE and DASH
Number of subjects: 132
Study 35026396 — intervention group
Group type: EXPERIMENTAL
Intervention: Inhaled nebulized 30 mg sodium nitrite twice a day for 12 weeks
Number of subjects: 11
Study 35026396 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study 32706859 — intervention group
Group type: EXPERIMENTAL
Intervention: Remdesivir
Number of subjects: 1130
Study 32706859 — intervention group
Group type: COMPARATOR
Intervention: Standard of Care
Number of subjects: 1130
Study 32366427 — intervention group
Group type: EXPERIMENTAL
Intervention: TissuGlu®
Number of subjects: 70
Study 32366427 — intervention group
Group type: COMPARATOR
Intervention: Drain
Number of subjects: 70
Study 33986493 — intervention group
Group type: COMPARATOR
Intervention: 0 mg caffeine (11 g of decaffeinated coffee)
Number of subjects: 25
Study 33986493 — intervention group
Group type: EXPERIMENTAL
Intervention: 200 mg caffeine (5.5 g of caffeinated plus 5.5 g of decaffeinated coffee)
Number of subjects: 25
Study 33986493 — intervention group
Group type: EXPERIMENTAL
Intervention: 400 mg caffeine (11 g of caffeinated coffee)
Number of subjects: 25
Study 32481473 — intervention group
Group type: EXPERIMENTAL
Intervention: RT plus CCSGs
Number of subjects: 40
Study 32481473 — intervention group
Group type: COMPARATOR
Intervention: RT
Number of subjects: 40
Study 36045392 — intervention group
Group type: EXPERIMENTAL
Intervention: Practice change intervention including Brief advice to abstain from alcohol and information about potential risks; referral to phone coaching service for medium-risk and Drug and Alcohol Service for high-risk women.
Number of subjects: 3850
Study 36045392 — intervention group
Group type: COMPARATOR
Intervention: Control group (pre-intervention) with no intervention applied.
Number of subjects: 3850
Study 34466793 — intervention group
Group type: EXPERIMENTAL
Intervention: Emotional Freedom Techniques (EFT) applied for 16 weeks in the immediate treatment group (ITG)
Number of subjects: 121
Study 34466793 — intervention group
Group type: COMPARATOR
Intervention: Wait-list control (WLC) group, who started EFT after 8 weeks
Number of subjects: 121
Study 34466793 — intervention group
Group type: EXPERIMENTAL
Intervention: EFT
Number of subjects: 121
Study 33393364 — intervention group
Group type: EXPERIMENTAL
Intervention: Individual Cognitive Stimulation Therapy (iCST), 40 sessions over 20 weeks
Number of subjects: 40
Study 33393364 — intervention group
Group type: COMPARATOR
Intervention: Waiting list control group
Number of subjects: 40
Study 32538123 — intervention group
Group type: EXPERIMENTAL
Intervention: Targeted Behavioral Therapy (TBT)
Number of subjects: 20
Study 32538123 — intervention group
Group type: COMPARATOR
Intervention: Cognitive-Behavioral Therapy (CBT)
Number of subjects: 20
Study 32586932 — intervention group
Group type: EXPERIMENTAL
Intervention: X-82 50mg
Number of subjects: 157
Study 32586932 — intervention group
Group type: EXPERIMENTAL
Intervention: X-82 100mg
Number of subjects: 157
Study 32586932 — intervention group
Group type: EXPERIMENTAL
Intervention: X-82 200mg
Number of subjects: 157
Study 32586932 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 157
Study 32586932 — intervention group
Group type: EXPERIMENTAL
Intervention: X-82 (all dosages)
Number of subjects: 157
Study 33352724 — intervention group
Group type: EXPERIMENTAL
Intervention: HFCS-SB (high fructose corn syrup)
Number of subjects: 131
Study 33352724 — intervention group
Group type: EXPERIMENTAL
Intervention: Glucose-SB
Number of subjects: 131
Study 33352724 — intervention group
Group type: EXPERIMENTAL
Intervention: Sucrose-SB
Number of subjects: 131
Study 33352724 — intervention group
Group type: EXPERIMENTAL
Intervention: Fructose-SB
Number of subjects: 131
Study 33352724 — intervention group
Group type: EXPERIMENTAL
Intervention: HFCS-SB
Number of subjects: 131
Study 33352724 — intervention group
Group type: COMPARATOR
Intervention: Aspartame-SB
Number of subjects: 131
Study 36065155 — intervention group
Group type: EXPERIMENTAL
Intervention: Varenicline
Number of subjects: 320
Study 36065155 — intervention group
Group type: EXPERIMENTAL
Intervention: Nicotine replacement therapy
Number of subjects: 320
Study 36065155 — intervention group
Group type: COMPARATOR
Intervention: Prior hospitalisation
Number of subjects: 320
Study 36065155 — intervention group
Group type: COMPARATOR
Intervention: Employment status
Number of subjects: 320
Study 36065155 — intervention group
Group type: EXPERIMENTAL
Intervention: Stress or anxiety, urges to smoke, lack of motivation
Number of subjects: 320
Study 34485057 — intervention group
Group type: EXPERIMENTAL
Intervention: Ball endometrial ablation
Number of subjects: 44
Study 34485057 — intervention group
Group type: COMPARATOR
Intervention: Transcervical resection of the endometrium (TCRE)
Number of subjects: 44
Study 34485057 — intervention group
Group type: COMPARATOR
Intervention: TCRE
Number of subjects: 44
Study 35534349 — intervention group
Group type: EXPERIMENTAL
Intervention: Synergy drug eluting stent (DES)
Number of subjects: 170
Study 35534349 — intervention group
Group type: COMPARATOR
Intervention: Xience drug eluting stent (DES)
Number of subjects: 170
Study 35534349 — intervention group
Group type: EXPERIMENTAL
Intervention: Both Synergy and Xience
Number of subjects: 170
Study 35534349 — intervention group
Group type: EXPERIMENTAL
Intervention: Synergy stents
Number of subjects: 170
Study 35534349 — intervention group
Group type: EXPERIMENTAL
Intervention: Xience stents
Number of subjects: 170
Study 34562202 — intervention group
Group type: EXPERIMENTAL
Intervention: High-Intensity Interval Training (HIIT)
Number of subjects: 25
Study 34562202 — intervention group
Group type: COMPARATOR
Intervention: No intervention (Control)
Number of subjects: 25
Study 34842579 — intervention group
Group type: EXPERIMENTAL
Intervention: Acupuncture
Number of subjects: 2725
Study 34582545 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-Carb diet
Number of subjects: 164
Study 33320406 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical minoxidil gel 5%
Number of subjects: 60
Study 33320406 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical spironolactone gel 1%
Number of subjects: 60
Study 33320406 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined minoxidil 5% and spironolactone 1% gel
Number of subjects: 60
Study 33320406 — intervention group
Group type: EXPERIMENTAL
Intervention: Histopathological examination
Number of subjects: 60
Study 33278175 — intervention group
Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stents
Number of subjects: 1236
Study 33278175 — intervention group
Group type: EXPERIMENTAL
Intervention: Everolimus-eluting stents
Number of subjects: 1236
Study 33278175 — intervention group
Group type: COMPARATOR
Intervention: Zotarolimus-eluting stents
Number of subjects: 1236
Study 32445736 — intervention group
Group type: EXPERIMENTAL
Intervention: Telehealth lifestyle intervention
Number of subjects: 200
Study 32445736 — intervention group
Group type: COMPARATOR
Intervention: Usual antenatal care
Number of subjects: 200
Study 32815559 — intervention group
Group type: EXPERIMENTAL
Intervention: FL Evaluation Index (FLEX)
Number of subjects: 1004
Study 32815559 — intervention group
Group type: COMPARATOR
Intervention: FLIPI
Number of subjects: 1004
Study 32815559 — intervention group
Group type: COMPARATOR
Intervention: FLIPI-2
Number of subjects: 1004
Study 32815559 — intervention group
Group type: COMPARATOR
Intervention: PRIMA-Prognostic Index (PRIMA-PI)
Number of subjects: 1004
Study 32815559 — intervention group
Group type: EXPERIMENTAL
Intervention: FL Evaluation Index (FLEX) in SABRINA trial
Number of subjects: 1004
Study 35597332 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol-based potassium supplementation (oral potassium chloride to maintain serum potassium of 4-5 mEq/L)
Number of subjects: 167
Study 35597332 — intervention group
Group type: COMPARATOR
Intervention: Conventional potassium supplementation (reactive supplementation when serum potassium is <3.5 mEq/L)
Number of subjects: 167
Study 35597332 — intervention group
Group type: EXPERIMENTAL
Intervention: Protocol-based potassium supplementation
Number of subjects: 167
Study 35597332 — intervention group
Group type: COMPARATOR
Intervention: Conventional potassium supplementation
Number of subjects: 167
Study 34674862 — intervention group
Group type: EXPERIMENTAL
Intervention: Transcatheter edge-to-edge repair (TEER)
Number of subjects: 372
Study 34674862 — intervention group
Group type: COMPARATOR
Intervention: Guideline-directed medical therapy (GDMT)
Number of subjects: 372
Study 34674862 — intervention group
Group type: EXPERIMENTAL
Intervention: Advanced RV-PA uncoupling
Number of subjects: 372
Study 32817595 — intervention group
Group type: EXPERIMENTAL
Intervention: Cortex Phellodendri Compound Fluid (CPCF)
Number of subjects: 720
Study 32817595 — intervention group
Group type: COMPARATOR
Intervention: Kangfuxin solution (KFS)
Number of subjects: 720
Study 34560665 — intervention group
Group type: EXPERIMENTAL
Intervention: Incremental Cycling Test (INC)
Number of subjects: 19
Study 34560665 — intervention group
Group type: EXPERIMENTAL
Intervention: Decremental Cycling Test (DEC)
Number of subjects: 19
Study 34349568 — intervention group
Group type: EXPERIMENTAL
Intervention: Silicone device (Derma-Stent)
Number of subjects: 50
Study 34349568 — intervention group
Group type: COMPARATOR
Intervention: Gauze packing
Number of subjects: 50
Study 36085879 — intervention group
Group type: EXPERIMENTAL
Intervention: 3kHz stimulation
Number of subjects: 25
Study 36085879 — intervention group
Group type: COMPARATOR
Intervention: Sham
Number of subjects: 25
Study 33982408 — intervention group
Group type: EXPERIMENTAL
Intervention: pegvorhyaluronidase alfa (PVHA) plus docetaxel
Number of subjects: 15
Study 35896988 — intervention group
Group type: EXPERIMENTAL
Intervention: Galcanezumab 120 mg (with 240 mg loading dose)
Number of subjects: 520
Study 35896988 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 520
Study 33401953 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin exposure in anthracycline-treated women
Number of subjects: 1056
Study 33401953 — intervention group
Group type: COMPARATOR
Intervention: Unexposed to statins in anthracycline-treated women
Number of subjects: 1056
Study 33401953 — intervention group
Group type: EXPERIMENTAL
Intervention: Statin exposure in trastuzumab-treated women
Number of subjects: 1056
Study 33401953 — intervention group
Group type: COMPARATOR
Intervention: Unexposed to statins in trastuzumab-treated women
Number of subjects: 1056
Study 32250171 — intervention group
Group type: EXPERIMENTAL
Intervention: One standard serving (∼11‐15 g) daily of a preferred alcoholic beverage
Number of subjects: 7800
Study 32250171 — intervention group
Group type: COMPARATOR
Intervention: Abstention
Number of subjects: 7800
Study 616119517 — intervention group
Group type: EXPERIMENTAL
Intervention: Diet plus acetazolamide
Number of subjects: 126
Study 616119517 — intervention group
Group type: COMPARATOR
Intervention: Diet plus placebo
Number of subjects: 126
Study 33765687 — intervention group
Group type: EXPERIMENTAL
Intervention: One-week health program of the Social Insurance for Agriculture, Forestry and Horticulture (SVLFG)
Number of subjects: 56
Study 33765687 — intervention group
Group type: COMPARATOR
Intervention: Comparison group (no intervention)
Number of subjects: 56
Study 34794685 — intervention group
Group type: EXPERIMENTAL
Intervention: β-blocker withdrawal (arm A: n = 26)
Number of subjects: 52
Study 34794685 — intervention group
Group type: COMPARATOR
Intervention: Continuing β-blocker treatment (arm B: n = 26)
Number of subjects: 52
Study 35045155 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal approach (suture rectopexy)
Number of subjects: 134
Study 35045155 — intervention group
Group type: EXPERIMENTAL
Intervention: Abdominal approach (resection rectopexy)
Number of subjects: 134
Study 35045155 — intervention group
Group type: EXPERIMENTAL
Intervention: Perineal approach (Delorme's procedure)
Number of subjects: 134
Study 35045155 — intervention group
Group type: EXPERIMENTAL
Intervention: Perineal approach (Altemeier's procedure)
Number of subjects: 134
Study 35045155 — intervention group
Group type: COMPARATOR
Intervention: Perineal approach
Number of subjects: 134
Study 35045155 — intervention group
Group type: COMPARATOR
Intervention: Abdominal approach
Number of subjects: 134
Study 33048342 — intervention group
Group type: EXPERIMENTAL
Intervention: Remote ischaemic preconditioning (RIPC) - four cycles of 5 minutes forearm ischaemia and reperfusion.
Number of subjects: 38
Study 33048342 — intervention group
Group type: COMPARATOR
Intervention: Control (standard treatment)
Number of subjects: 38
Study 35094228 — intervention group
Group type: EXPERIMENTAL
Intervention: EnVista IOL (MX60)
Number of subjects: 25
Study 35094228 — intervention group
Group type: COMPARATOR
Intervention: Acrysof IQ IOL (SN60WF)
Number of subjects: 25
Study 35094228 — intervention group
Group type: EXPERIMENTAL
Intervention: Both IOLs
Number of subjects: 25
Study 33760077 — intervention group
Group type: EXPERIMENTAL
Intervention: Decision Support Interventions (DESIs)
Number of subjects: 1339
Study 33760077 — intervention group
Group type: COMPARATOR
Intervention: Usual Care
Number of subjects: 1339
Study 35119467 — intervention group
Group type: EXPERIMENTAL
Intervention: Not available
Number of subjects: 0
Study 33798751 — intervention group
Group type: COMPARATOR
Intervention: Intracoronal bleaching treatment with 35 % hydrogen peroxide for 40 min (Control group)
Number of subjects: 24
Study 33798751 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronal bleaching treatment assisted with Er,Cr:YSGG laser (2780 nm) operating at 1.25 W for 30 s
Number of subjects: 24
Study 33798751 — intervention group
Group type: EXPERIMENTAL
Intervention: Intracoronal bleaching treatment assisted with Er,Cr:YSGG laser (2780 nm) operating at 2.5 W for 30 s
Number of subjects: 24
Study 32087600 — intervention group
Group type: EXPERIMENTAL
Intervention: Aquatic Exercise (AE)
Number of subjects: 36
Study 32087600 — intervention group
Group type: EXPERIMENTAL
Intervention: Kinesio Taping (KT)
Number of subjects: 36
Study 32087600 — intervention group
Group type: COMPARATOR
Intervention: Nontreatment Control
Number of subjects: 36
Study 33431281 — intervention group
Group type: EXPERIMENTAL
Intervention: Ischemic compression (90 seconds over each TrP)
Number of subjects: 29
Study 33431281 — intervention group
Group type: COMPARATOR
Intervention: Control group (no treatment)
Number of subjects: 29
Study 32514005 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-caloric diet (LCD, 800 kcal/d for 8 weeks)
Number of subjects: 375
Study 32514005 — intervention group
Group type: EXPERIMENTAL
Intervention: Plasma omics model based on baseline parameters
Number of subjects: 375
Study 33119180 — intervention group
Group type: EXPERIMENTAL
Intervention: Vergence/accommodative therapy
Number of subjects: 115
Study 33119180 — intervention group
Group type: COMPARATOR
Intervention: Placebo therapy
Number of subjects: 115
Study 33126096 — intervention group
Group type: EXPERIMENTAL
Intervention: Training healthcare workers as change agents in a Social and Behavioural Change Communication workshop, supported by a social marketing campaign.
Number of subjects: 652
Study 33126096 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified in detail).
Number of subjects: 652
Study 33586090 — intervention group
Group type: EXPERIMENTAL
Intervention: 0.01% atropine eye drops
Number of subjects: 171
Study 33586090 — intervention group
Group type: COMPARATOR
Intervention: Placebo eye drops
Number of subjects: 171
Study 32941094 — intervention group
Group type: EXPERIMENTAL
Intervention: Air abrasion with silica‐coated 30‐m Al2O3 particles (Groups 2 & 6)
Number of subjects: 240
Study 32941094 — intervention group
Group type: EXPERIMENTAL
Intervention: Air abrasion with universal primer (Groups 3 & 7)
Number of subjects: 240
Study 32941094 — intervention group
Group type: EXPERIMENTAL
Intervention: Air abrasion with universal adhesive (Groups 4 & 8)
Number of subjects: 240
Study 32941094 — intervention group
Group type: EXPERIMENTAL
Intervention: Activa (Groups 6 & 8)
Number of subjects: 240
Study 32941094 — intervention group
Group type: EXPERIMENTAL
Intervention: Bulk‐fill flowable resin‐based composite (Bulk‐RBC) (Groups 1‐4)
Number of subjects: 240
Study 32941094 — intervention group
Group type: COMPARATOR
Intervention: Control without surface treatment (Groups 1 & 5)
Number of subjects: 240
Study 33000478 — intervention group
Group type: EXPERIMENTAL
Intervention: Additional 10 minutes of 1-on-1 instruction by a trained physical therapy student or dental faculty member
Number of subjects: 41
Study 35672926 — intervention group
Group type: EXPERIMENTAL
Intervention: Ocrelizumab
Number of subjects: 0
Study 35672926 — intervention group
Group type: COMPARATOR
Intervention: Interferon beta‐1a (IFNβ1a) / placebo
Number of subjects: 0
Study 35452688 — intervention group
Group type: COMPARATOR
Intervention: Intravenous infusion amiodarone
Number of subjects: 200
Study 35452688 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral propafenone
Number of subjects: 200
Study 33666322 — intervention group
Group type: EXPERIMENTAL
Intervention: Prolonged Exposure (PE)
Number of subjects: 61
Study 33666322 — intervention group
Group type: COMPARATOR
Intervention: Virtual Reality Exposure (VRE)
Number of subjects: 61
Study 35090799 — intervention group
Group type: EXPERIMENTAL
Intervention: Sodium nitrate (NaNO3) supplementation for 8 weeks
Number of subjects: 21
Study 35090799 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 21
Study 34204415 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity percutaneous electrolysis (0.3 mA × 90 s)
Number of subjects: 72
Study 34204415 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity percutaneous electrolysis (three bouts of 3 mA × 3 s)
Number of subjects: 72
Study 34204415 — intervention group
Group type: EXPERIMENTAL
Intervention: Needling intervention without electrical current
Number of subjects: 72
Study 34204415 — intervention group
Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 72
Study 34204415 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-intensity percutaneous electrolysis
Number of subjects: 72
Study 34204415 — intervention group
Group type: EXPERIMENTAL
Intervention: High-intensity percutaneous electrolysis
Number of subjects: 72
Study 35082960 — intervention group
Group type: EXPERIMENTAL
Intervention: Breathing exercise using bubble blower (BE) + Inferior Alveolar Nerve Block (IANB)
Number of subjects: 35
Study 35082960 — intervention group
Group type: COMPARATOR
Intervention: Routine Inferior Alveolar Nerve Block (IANB)
Number of subjects: 35
Study 33630179 — intervention group
Group type: EXPERIMENTAL
Intervention: Low time pressure (10-s time per trial)
Number of subjects: 0
Study 33630179 — intervention group
Group type: COMPARATOR
Intervention: High time pressure (5-s time per trial)
Number of subjects: 0
Study 33630179 — intervention group
Group type: COMPARATOR
Intervention: Automation support (85% reliability)
Number of subjects: 0
Study 33630179 — intervention group
Group type: COMPARATOR
Intervention: High time pressure in target-absent trials
Number of subjects: 0
Study 33630179 — intervention group
Group type: EXPERIMENTAL
Intervention: Target expectancy (predictable location of targets)
Number of subjects: 0
Study 36254693 — intervention group
Group type: EXPERIMENTAL
Intervention: empagliflozin 10 mg once daily
Number of subjects: 530
Study 36254693 — intervention group
Group type: COMPARATOR
Intervention: placebo
Number of subjects: 530
Study 34411217 — intervention group
Group type: EXPERIMENTAL
Intervention: Flapless guided surgery
Number of subjects: 10
Study 34411217 — intervention group
Group type: COMPARATOR
Intervention: Conventional flap surgery
Number of subjects: 10
Study 33216773 — intervention group
Group type: EXPERIMENTAL
Intervention: Home-based HIV testing services (HBHTS)
Number of subjects: 1000
Study 36459908 — intervention group
Group type: EXPERIMENTAL
Intervention: Topical olive oil dressing plus standard care (wound irrigation with normal saline and oral antibiotics) for four weeks
Number of subjects: 60
Study 36459908 — intervention group
Group type: COMPARATOR
Intervention: Standard care alone
Number of subjects: 60
Study 33454241 — intervention group
Group type: EXPERIMENTAL
Intervention: APOB mutation carriers (n=40, LDL-C ≤ 50 mg/dL)
Number of subjects: 120
Study 33454241 — intervention group
Group type: COMPARATOR
Intervention: Wild-type controls (n=40, LDL-C ≤ 50 mg/dL)
Number of subjects: 120
Study 35802811 — intervention group
Group type: EXPERIMENTAL
Intervention: Moderate exercise (45 minutes)
Number of subjects: 56
Study 35802811 — intervention group
Group type: EXPERIMENTAL
Intervention: Vigorous exercise (30 minutes)
Number of subjects: 56
Study 35802811 — intervention group
Group type: COMPARATOR
Intervention: Control (no intervention)
Number of subjects: 56
Study 33559358 — intervention group
Group type: EXPERIMENTAL
Intervention: Microcurrent application to the heart
Number of subjects: 10
Study 34807713 — intervention group
Group type: EXPERIMENTAL
Intervention: Sacubitril/valsartan
Number of subjects: 4796
Study 34807713 — intervention group
Group type: COMPARATOR
Intervention: Valsartan
Number of subjects: 4796
Study 35724585 — intervention group
Group type: EXPERIMENTAL
Intervention: Economic support
Number of subjects: 157
Study 35724585 — intervention group
Group type: EXPERIMENTAL
Intervention: Combined economic support, CSE and community dialogue
Number of subjects: 157
Study 35724585 — intervention group
Group type: EXPERIMENTAL
Intervention: CSE and community dialogue
Number of subjects: 157
Study 35724585 — intervention group
Group type: COMPARATOR
Intervention: Control
Number of subjects: 157
Study 35934006 — intervention group
Group type: EXPERIMENTAL
Intervention: Boost after whole breast irradiation (WBI)
Number of subjects: 1608
Study 35934006 — intervention group
Group type: COMPARATOR
Intervention: No boost after whole breast irradiation (WBI)
Number of subjects: 1608
Study 35934006 — intervention group
Group type: EXPERIMENTAL
Intervention: Boost after conventional WBI (50 Gy in 25 fractions)
Number of subjects: 1608
Study 35934006 — intervention group
Group type: COMPARATOR
Intervention: No boost after conventional WBI (50 Gy in 25 fractions)
Number of subjects: 1608
Study 35934006 — intervention group
Group type: EXPERIMENTAL
Intervention: Boost after hypofractionated WBI (42.5 Gy in 16 fractions)
Number of subjects: 1608
Study 35934006 — intervention group
Group type: COMPARATOR
Intervention: No boost after hypofractionated WBI (42.5 Gy in 16 fractions)
Number of subjects: 1608
Study 33733893 — intervention group
Group type: EXPERIMENTAL
Intervention: Liquefied petroleum gas (LPG) stove and 18-month supply of free fuel
Number of subjects: 3200
Study 33733893 — intervention group
Group type: EXPERIMENTAL
Intervention: Visual messages to support LPG use
Number of subjects: 3200